Literature DB >> 16421155

A new treatment for polyarteritis nodosa.

Kenneth Wu1, David Throssell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16421155     DOI： 10.1093/ndt/gfk082

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  7 in total

Review 1.  Infliximab for the treatment of refractory polyarteritis nodosa.

Authors:  Shira Ginsberg; Itzhak Rosner; Gleb Slobodin; Michael Rozenbaum; Lisa Kaly; Nizar Jiries; Nina Boulman; Abid Awisat; Haya Hussein; Irina Novofastovski; Amal Silawy; Doron Rimar
Journal:  Clin Rheumatol       Date:  2019-04-10       Impact factor: 2.980

Review 2.  Unmet Needs in the Pathogenesis and Treatment of Vasculitides.

Authors:  Francesco Muratore; Giulia Pazzola; Alessandra Soriano; Nicolò Pipitone; Stefania Croci; Martina Bonacini; Luigi Boiardi; Carlo Salvarani
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

Review 3.  Anti-TNF-alpha therapy and systemic vasculitis.

Authors:  Pierre-André Jarrot; Gilles Kaplanski
Journal:  Mediators Inflamm       Date:  2014-02-27       Impact factor: 4.711

4.  Adalimumab therapy in hepatitis B virus-negative polyarteritis nodosa: A case report.

Authors:  Chrong-Reen Wang; Chao-Chun Yang
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

Review 5.  Medium-size-vessel vasculitis.

Authors:  Michael J Dillon; Despina Eleftheriou; Paul A Brogan
Journal:  Pediatr Nephrol       Date:  2009-11-28       Impact factor: 3.714

6.  The Successful Treatment of Refractory Polyarteritis Nodosa Using Infliximab.

Authors:  Satoko Matsuo; Keigo Hayashi; Eisaku Morimoto; Ayako Kato; Ken-Ei Sada; Haruki Watanabe; Mariko Takano-Narazaki; Katsue Sunahori-Watanabe; Tomoko Kawabata; Jun Wada
Journal:  Intern Med       Date:  2017-06-01       Impact factor: 1.271

Review 7.  Vasculitis: From Target Molecules to Novel Therapeutic Approaches.

Authors:  Sang-Wan Chung
Journal:  Biomedicines       Date:  2021-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.